Digital Laparoscopy Articles & Analysis
12 news found
This approval will provide Senhance Digital Laparoscopy programs in Europe access to this technology. Fourth Quarter and Full Year 2021 Revenue For the quarter ended December 31, 2021, the Company estimates preliminary unaudited revenue of approximately $2.1 - $2.5 million. ...
About Asensus Surgical, Inc. Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy ...
” Asensus Surgical's technology platform, Senhance Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning. ...
With features such as precise real-time intraoperative measurements and digital tags, the ISU’s intraoperative intelligence sets Senhance apart from other current and future robotic ...
The ISU is utilized with the Company’s Senhance Surgical System which enables Digital Laparoscopy. The initial features of the ISU enable machine vision-driven control of the camera for a surgeon by responding to commands and recognizing certain objects and locations in the surgical field, and allow a surgeon to change the visualized field of view using the ...
” Asensus Surgical's technology platform, Senhance Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning. ...
About Asensus Surgical, Inc. Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking the clinical intelligence to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the ...
’’ Asensus Surgical's technology platform, Senhance Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning. ...
David has a deep understanding of the Asensus business strategy and our potential to revolutionize digital surgery as well as an established track record of successfully leading growth initiatives within medical technology companies. ...
’’ Asensus Surgical's technology platform, Senhance Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning. ...
During the first half of 2021, the Company expects to achieve the following regulatory milestones: File for FDA 510(k) clearance for articulating instruments File for FDA 510(k) clearance for the next generation ISU features During the first half of 2021, the Company expects to publish clinical papers in peer reviewed journals on the following subjects: Health economic studies comparing ...
(NYSE American: TRXC) , a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced the Company has received an additional FDA clearance for the Senhance Surgical System which allows for indication expansion in general surgery in the United States. Asensus Surgical's ...